Medscape Medical News, June 04, 2013 Liposomal Daunorubicin: Less Cardiotoxicity in Pediatric AML Induction therapy ... 2013 Many Fanconi Anemia Patients Fare Well After Transplant Patients ...

Secondary acute myeloid leukemia (AML) is a blood cancer that arises from other blood disorders or previous cancer treatment. Those with secondary AML tend to have a less favorable outlook than ...

My name is Faizan Raza, and I am a 26-year-old battling Fanconi anemia, a rare genetic disorder, coupled with Myelodysplastic Syndrome (MDS). Due to the severity of my condition, I urgently require a ...

Hematologic oncologist Eytan Stein (shown here with nurse practitioner Coleen Ranaghan) has led the development of several new drugs for acute myeloid leukemia. Acute myeloid leukemia (AML) is one of ...

Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of ...

Oct. 9, 2024 — Researchers have created a CRISPR-based rapid molecular diagnostic for two forms of leukemia that are driven by mutations that involve gene fusions. The technology accurately ...

Reported preliminary data from the ongoing SPOTLIGHT Phase 1b/2a study of subcutaneous briquilimab in adult participants with cold urticaria (ColdU) or symptomatic dermographism (SD), the two most ...

Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the ...